LTGO — Latigo Biotherapeutics, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 2056611 ·
Last close
$16.70
Market Cap
—
52W High
$25.93
52W Low
$16.19
ADV30
317,023
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | 64,760,000 | 55,003,000 | — |
| Mar 2026 | 0 | — | -23,436,000 | -22,961,000 | 50,581,000 | 42,177,000 | 303,160,000 |
| Jun 2025 | — | — | -25,745,000 | — | — | — | — |
| Mar 2025 | 0 | — | -21,512,000 | -20,952,000 | — | — | — |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-48,226,000
Investing CF
$-102,000
Financing CF
$99,204,000
CapEx
$-102,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-09-06
Balance + Analyst (yfinance extras)
Retained Earnings
$-266,092,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-44,948,000
Pretax Income TTM
$-43,913,000
Interest Exp TTM
—
Analysts
4
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -110,392,000 | -109,167,000 | 75,516,000 | 307,190,000 | -231,674,000 | -97,557,000 |
| Dec 2024 | 0 | -63,451,000 | -61,183,000 | 22,864,000 | 152,463,000 | -129,599,000 | -50,955,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.03T | $1157.08 | — |
| JNJ | JOHNSON & JOHNSON | $638.00B | $264.74 | — |
| ABBV | AbbVie Inc. | $462.26B | $261.59 | — |
| MRK | Merck & Co., Inc. | $358.50B | $145.31 | — |
| NVS | NOVARTIS AG | $270.98B | $142.57 | — |
News headlines (Yahoo Finance, 1h cache)
The Market Barely Knows These 2 IPO Stocks — Goldman Sachs Says ‘Buy’
2026-09-08 18:01 · Yahoo
Latigo Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
2026-09-03 20:05 · Yahoo
Latigo Biotherapeutics (LTGO) On IPO And Trial Data Looks About Right Valued
2026-08-10 03:19 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.